Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Lichterfeld

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Science Translational Medicine|November 29, 2019
Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profilePilar Garcia-Broncano, Shivaali Maddali, Kevin B Einkauf, et al.
Journal of Virology|September 29, 2005
De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infectionTodd M Allen, Xu G Yu, Elizabeth T Kalife, et al.
The Journal of Experimental Medicine|November 21, 2007
A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsMathias Lichterfeld, Daniel G Kavanagh, Katie L Williams, et al.
Immunity|December 20, 2014
Dysfunctional HIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosisGaurav D Gaiha, Kevin J McKim, Matthew Woods, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2011
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individualsMathias Lichterfeld, Rajesh T Gandhi, Rachel P Simmons, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Cell|February 17, 2024
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2aMarie Armani-Tourret, Ce Gao, Ciputra Adijaya Hartana, et al.
Clinical Immunology (Orlando, Fla.)|April 1, 2022
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 6, 2026
Proviral HIV-1 DNA Below Detection in Early Treated Adolescents After Prior Treatment InterruptionKavidha Reddy, Louise Kuhn, Shaun Barnabas, et al.
Journal of Virology|March 30, 2005
The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine designMarcus Altfeld, Todd M Allen, Elizabeth T Kalife, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Science Translational Medicine|November 29, 2019
Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profilePilar Garcia-Broncano, Shivaali Maddali, Kevin B Einkauf, et al.
Journal of Virology|September 29, 2005
De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infectionTodd M Allen, Xu G Yu, Elizabeth T Kalife, et al.
The Journal of Experimental Medicine|November 21, 2007
A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsMathias Lichterfeld, Daniel G Kavanagh, Katie L Williams, et al.
Immunity|December 20, 2014
Dysfunctional HIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosisGaurav D Gaiha, Kevin J McKim, Matthew Woods, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2011
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individualsMathias Lichterfeld, Rajesh T Gandhi, Rachel P Simmons, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Cell|February 17, 2024
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2aMarie Armani-Tourret, Ce Gao, Ciputra Adijaya Hartana, et al.
Clinical Immunology (Orlando, Fla.)|April 1, 2022
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 6, 2026
Proviral HIV-1 DNA Below Detection in Early Treated Adolescents After Prior Treatment InterruptionKavidha Reddy, Louise Kuhn, Shaun Barnabas, et al.
Journal of Virology|March 30, 2005
The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine designMarcus Altfeld, Todd M Allen, Elizabeth T Kalife, et al.
Pageof 17